Wearable cardioverter defibrillator: bridging for implantable defibrillators in left ventricular assist device patients
- 6 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Heart Failure Reviews
- Vol. 26 (4), 763-765
- https://doi.org/10.1007/s10741-020-10064-8
Abstract
There is currently conflicting data available regarding the use of implantable cardioverter-defibrillators (ICD) in left ventricular assist device (LVAD) patients. While the benefit of an ICD in heart failure patients is well demonstrated, such benefit has failed to reach the LVAD population. In lack of randomized control trial data on the topic of ICD use in LVAD recipients, major societal guidelines are in disagreement when comes to the topic of routine implantation of a permanent defibrillator in prospective ventricular assist device patients. Alternative permanent defibrillator strategies have been suggested for the LVAD population such as subcutaneous implantable cardioverter defibrillators (S-ICDs) but eligibility of patients for such practice remains disappointing. Although most of the heart failure patients undergoing LVAD implantation already bear an ICD, clinicians are left with the decision of de novo implanting an ICD in an important number of patients. Wearable cardioverter defibrillators could prove beneficial in LVAD recipients by utilizing them as a bridge to decision towards the implantation of a permanent defibrillator.Keywords
This publication has 14 references indexed in Scilit:
- The Society of Thoracic Surgeons Intermacs 2019 Annual Report: The Changing Landscape of Devices and IndicationsThe Annals of Thoracic Surgery, 2020
- Current Review of Implantable Cardioverter Defibrillator Use in Patients With Left Ventricular Assist DeviceCurrent Heart Failure Reports, 2019
- Implantable Cardioverter Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices: Utilization Patterns, Related Procedures, and ComplicationsJournal of the American Heart Association, 2019
- 2019 EACTS Expert Consensus on long-term mechanical circulatory supportEuropean Journal of Cardio-Thoracic Surgery, 2019
- Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients: A Scientific Statement From the American Heart AssociationCirculation, 2019
- Correction to: 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm SocietyCirculation, 2018
- Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist DeviceJACC: Heart Failure, 2017
- The role of implantable cardioverter defibrillators in patients bridged to transplantation with a continuous-flow left ventricular assist device: A propensity score matched analysisThe Journal of Heart and Lung Transplantation, 2016
- Cardiovascular Implantable Electronic Device Infections in Left Ventricular Assist Device RecipientsPacing and Clinical Electrophysiology, 2013
- The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summaryThe Journal of Heart and Lung Transplantation, 2013